Medical Research Council media release
Scientists have for the first time used regenerative medicine to fully restore a degenerated organ in a living animal, a discovery that could pave the way for future human therapies.
The team from the Medical Research Council (MRC) Centre for Regenerative Medicine, at the University of Edinburgh, rebuilt the thymus of very old mice by reactivating a natural mechanism that gets shut down with age.
It was a typical morning – trying to juggle experiments, trying not to make mistakes, trying hard to get results….sometimes life can be very ‘trying’ indeed… but then I’m not affected by motor neurone disease (MND) - and what a privilege it is for me to be able to rush around, to go to work and, hopefully one day, discover something that can make a difference. I am reminded of this as I stumble out of the morning into a less ordinary afternoon - stepping away from the bench and into the world of my boss, Prof Siddharthan Chandran.
Wie werden Stammzellen als Labormodell für Krankheiten genutzt? Dieser vierminütige Animationsfilm erklärt einfach und anschaulich, wie und wieso Zellen als Krankheitsmodelle genutzt werden.
Diese Animation wurde im Auftrag von Eurostemcell von Duncan Brown produziert. Der wissenschaftliche Inhalt, sowie die Stimme, wurde von Dr Dr Christian Unger zur Verfügung gestellt.
Dieses Video ist inhaltlich mit dem "factsheet on reprogrammed cells in disease modelling" verbunden (auf Englisch, deutsche Fassung in Entwicklung).
On 30th January, a research group from Japan unveiled a new and seemingly simple method for making stem cells in the lab. Since then, their unusual findings have been met with a mixture of excitement and skepticism. So what exactly did this group do, and what does it mean for stem cell research? Niamh Higgins, a Genetics and Cell Biology student at Dublin City University in Ireland, has been exploring this news for us. Read on to discover what she found.
Several new stem cell research projects are off the starting blocks, thanks to major funding from the European Commission’s Framework 7 Programme. We’re excited that four of the new projects are collaborating with EuroStemCell. They all focus on different disease areas and types of stem cells, but they all have a common goal: to understand how stem cells work and how to control them so they can be used in treatments for patients. Read on to find out more about the new research.
A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems.
The £5 million project may translate into new treatments that benefit older people and those who have received a bone marrow transplant.
It aims to develop stem cell therapies that can boost the immune system by repairing the thymus, an organ in the body located next to the heart that produces important immune cells.
